Neovasc Inc.

Recent News

  • Neovasc to Participate in H.C. Wainwright & Co. 22nd Annual Global Investment Conference

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - September 8, 2020) -  Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, today announced that its management team will be participating in the 22nd Annual H.C. Wainwright Global Investment Conference on September 14-16, 2020. Fred Colen, Neovasc's President and CEO, will present on September 15 at 3:30 pm...

    2020-09-08 5:10 PM ET
  • Neovasc Inc. Reports Results of Annual General Meeting of Shareholders

    Vancouver, British Columbia--(Newsfile Corp. - September 3, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") is pleased to announce the results of the votes on matters considered at its Annual General Meeting of Shareholders held on September 3, 2020 in Vancouver, B.C. (the "Meeting").At the Meeting, the shareholders of the Company (the "Shareholders") re-elected board members Steven Rubin, Paul Geyer, Doug Janzen, Norman Radow, Alexei Marko and Fred Colen to serve in office until the...

    2020-09-03 4:41 PM ET
  • Neovasc Announces Partial Prepayment of Convertible Debenture

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - August 17, 2020) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that Strul Medical Group LLC ("SMG") exercised 501,000 of the remaining 1,149,910 common share purchase warrants (the "May Warrants") issued pursuant to a Securities Purchase Agreement dated May 26, 2020 at an exercise price of US$2.634 per May Warrant for aggregate exercise proceeds to the Company of US$1,319,634.00 (the "Exercise Proceeds"). Using the Exercise Proceeds, the...

    2020-08-17 9:00 AM ET
  • Neovasc Provides Corporate Update

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - August 13, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), today provided a corporate update on progress towards its value creation strategies. Fred Colen, Chief Executive Officer of Neovasc, commented, "We are pleased to provide a corporate update to our investors as we have made meaningful progress against our value creation strategies. We have clear line of site to important milestones across each of our objectives and sufficient...

    2020-08-13 9:00 AM ET
  • Neovasc Announces Closing of US$12.6 Million Registered Direct Offering Priced At-The-Market

    Vancouver, British Columbia--(Newsfile Corp. - August 12, 2020) -  Neovasc Inc. (NASDAQ: NVCN)  (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has closed its previously announced registered direct offering (the "Offering") priced at-the-market under the Nasdaq rules of an aggregate of 4,532,772 common shares at a purchase price of US$2.77575 per common share for aggregate gross proceeds to the Company of approximately US$12.6 million, before deducting placement agent's fees and estimated expenses of the Offering payable by the...

    2020-08-12 2:41 PM ET
  • Neovasc Announces US$12.6 Million Registered Direct Offering Priced At-the-Market

    Vancouver, British Columbia--(Newsfile Corp. - August 10, 2020) -  Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 4,532,772 common shares at a purchase price of US$2.77575 per common share in a registered direct offering (the "Offering") priced at-the-market under the Nasdaq Capital Market (the "Nasdaq") rules for aggregate gross proceeds to the Company of approximately US$12.6 million, before...

    2020-08-10 8:00 AM ET
  • Neovasc Announces Second Quarter Financial Results

    Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - August 6, 2020) -  Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, today reported financial results for the second quarter ended June 30, 2020.Second Quarter HighlightsFollowing a COVID-related slowdown, experienced a sharp rebound in Reducer implants in June, meeting pre-COVID monthly Reducer targetConfirmed FDA Circulatory Systems Devices Panel Meeting...

    2020-08-06 4:05 PM ET
  • Neovasc Reducer(TM) Featured In Germany's Second Largest National Newspaper

    Vancouver, British Columbia and Minneapolis, Minnesota and Frankfurt, Germany--(Newsfile Corp. - July 24, 2020) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company")  announced today that the Neovasc Reducer™ (the "Reducer") was featured in a supplement titled: "Volkskrankheiten" or "Common Diseases" in Frankfurter Allgemeine Zeitung (FAZ), the second largest national newspaper by circulation in Germany. The supplement will be mailed to subscribers, reaching an estimated audience of almost 500,000 and should be available in the waiting areas of...

    2020-07-24 9:57 AM ET